Hashimoto M - Search Results

1

Ubiquitin-Specific Protease 2 in the Ventromedial Hypothalamus Modifies Blood Glucose Levels by Controlling Sympathetic Nervous Activation.

Hashimoto M, Fujimoto M, Konno K, Lee ML, Yamada Y, Yamashita K, Toda C, Tomura M, Watanabe M, Inanami O, Kitamura H. Hashimoto M, et al. J Neurosci. 2022 Jun 8;42(23):4607-4618. doi: 10.1523/JNEUROSCI.2504-21.2022. Epub 2022 May 3. J Neurosci. 2022. PMID: 35504726 Free PMC article.

2

Inhibition of ubiquitin-specific protease 2 causes accumulation of reactive oxygen species, mitochondria dysfunction, and intracellular ATP decrement in C2C12 myoblasts.

Hashimoto M, Saito N, Ohta H, Yamamoto K, Tashiro A, Nakazawa K, Inanami O, Kitamura H. Hashimoto M, et al. Physiol Rep. 2019 Jul;7(14):e14193. doi: 10.14814/phy2.14193. Physiol Rep. 2019. PMID: 31353872 Free PMC article.

3

USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.

Kitamura H, Hashimoto M. Kitamura H, et al. Among authors: hashimoto m. Int J Mol Sci. 2021 Jan 26;22(3):1209. doi: 10.3390/ijms22031209. Int J Mol Sci. 2021. PMID: 33530560 Free PMC article. Review.

4

Macrophage ubiquitin-specific protease 2 contributes to motility, hyperactivation, capacitation, and in vitro fertilization activity of mouse sperm.

Hashimoto M, Kimura S, Kanno C, Yanagawa Y, Watanabe T, Okabe J, Takahashi E, Nagano M, Kitamura H. Hashimoto M, et al. Cell Mol Life Sci. 2021 Mar;78(6):2929-2948. doi: 10.1007/s00018-020-03683-9. Epub 2020 Oct 26. Cell Mol Life Sci. 2021. PMID: 33104844 Free PMC article.

5

Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.

Moriya T, Hashimoto M, Matsushita H, Masuyama S, Yoshida R, Okada R, Furusawa A, Fujimura D, Wakiyama H, Kato T, Choyke PL, Kusumoto Y, Chtanova T, Kobayashi H, Tomura M. Moriya T, et al. Among authors: hashimoto m. Cancer Immunol Immunother. 2022 Dec;71(12):3099-3106. doi: 10.1007/s00262-022-03216-2. Epub 2022 May 28. Cancer Immunol Immunother. 2022. PMID: 35624180 Free PMC article.

6

Establishment of protocol for preparation of gene-edited bovine ear-derived fibroblasts for somatic cell nuclear transplantation.

Ishino T, Hashimoto M, Amagasa M, Saito N, Dochi O, Kirisawa R, Kitamura H. Ishino T, et al. Among authors: hashimoto m. Biomed Res. 2018;39(2):95-104. doi: 10.2220/biomedres.39.95. Biomed Res. 2018. PMID: 29669988 Free article.

7

Peptidoglycan endopeptidase MepM of uropathogenic Escherichia coli contributes to competitive fitness during urinary tract infections.

Huang WC, Dwija IBNP, Hashimoto M, Wu JJ, Wang MC, Kao CY, Lin WH, Wang S, Teng CH. Huang WC, et al. Among authors: hashimoto m. BMC Microbiol. 2024 May 30;24(1):190. doi: 10.1186/s12866-024-03290-9. BMC Microbiol. 2024. PMID: 38816687

8

C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Uchimoto T, Matsuda T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Higashio T, Tsuchida S, Nishimura K, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Fujita K, Kimura T, Ohno Y, Shiroki R, Uemura H, Azuma H. Uchimoto T, et al. Among authors: hashimoto m. Target Oncol. 2024 May 28. doi: 10.1007/s11523-024-01068-7. Online ahead of print. Target Oncol. 2024. PMID: 38807017

9

Subtotal esophagectomy and concurrent reconstruction with free jejunal flap for primary esophageal cancer after pancreatoduodenectomy.

Moriwake K, Noma K, Kawasaki K, Matsumoto T, Hashimoto M, Kato T, Maeda N, Tanabe S, Shirakawa Y, Fujiwara T. Moriwake K, et al. Among authors: hashimoto m. Surg Case Rep. 2024 May 22;10(1):128. doi: 10.1186/s40792-024-01919-5. Surg Case Rep. 2024. PMID: 38775882 Free PMC article.

10

Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.

Hara S, Mori K, Fukuokaya W, Tomomasa N, Oguchi T, Takahashi Y, Saito S, Katami J, Sano T, Kadena S, Hashimoto M, Yata Y, Nishi E, Suhara Y, Takamizawa S, Kurawaki S, Suzuki H, Miyajima K, Iwatani K, Urabe F, Ito K, Yanagisawa T, Tsuzuki S, Shimomura T, Kimura T. Hara S, et al. Among authors: hashimoto m. Int J Clin Oncol. 2024 May 20. doi: 10.1007/s10147-024-02548-6. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38769191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,570 results

Search Page